scholarly article | Q13442814 |
P50 | author | Simon Y Tang | Q42088751 |
P2093 | author name string | Tamara Alliston | |
P2860 | cites work | Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment | Q28255124 |
Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis | Q28265821 | ||
Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis | Q28288338 | ||
Load regulates bone formation and Sclerostin expression through a TGFβ-dependent mechanism | Q28484880 | ||
The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis | Q28593565 | ||
Anti-transforming growth factor ß antibody treatment rescues bone loss and prevents breast cancer metastasis to bone | Q28742851 | ||
Pharmacologic inhibition of the TGF-beta type I receptor kinase has anabolic and anti-catabolic effects on bone | Q30439859 | ||
A physical mechanism for coupling bone resorption and formation in adult human bone. | Q30485638 | ||
Tissue‐specific calibration of extracellular matrix material properties by transforming growth factor‐β and Runx2 in bone is required for hearing | Q30496822 | ||
Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-beta1 gene | Q32040444 | ||
TGFbeta inducible early gene-1 directly binds to, and represses, the OPG promoter in osteoblasts | Q33687067 | ||
TGF-beta regulates the mechanical properties and composition of bone matrix | Q34245000 | ||
Domain-specific mutations in TGFB1 result in Camurati-Engelmann disease. | Q34510617 | ||
A biomechanical analysis of the effects of resorption cavities on cancellous bone strength | Q34551219 | ||
Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures | Q34560491 | ||
Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation | Q35991461 | ||
Elevated TGF-beta2 signaling in dentin results in sex related enamel defects | Q36094583 | ||
TGFB1 mutations in four new families with Camurati-Engelmann disease: confirmation of independently arising LAP-domain-specific mutations | Q79972812 | ||
Inhibition of TGF-β signaling by 1D11 antibody treatment increases bone mass and quality in vivo | Q84293881 | ||
Matrix metalloproteinase-13 is required for osteocytic perilacunar remodeling and maintains bone fracture resistance | Q36153043 | ||
Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype | Q36236452 | ||
Current insights into the role of transforming growth factor-beta in bone resorption. | Q36283949 | ||
Injury-activated transforming growth factor β controls mobilization of mesenchymal stem cells for tissue remodeling | Q36342142 | ||
New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues | Q36366470 | ||
The role of the collagen matrix in skeletal fragility | Q36830308 | ||
Osteopoikilosis, short stature and mental retardation as key features of a new microdeletion syndrome on 12q14 | Q37004762 | ||
Matrix elasticity, cytoskeletal tension, and TGF-beta: the insoluble and soluble meet. | Q37107746 | ||
Demonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation. | Q37163219 | ||
TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation | Q37307155 | ||
TGF-beta and fibrosis in different organs - molecular pathway imprints | Q37524907 | ||
Alpha and beta human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria | Q37546341 | ||
TGF-β signal transduction spreading to a wider field: a broad variety of mechanisms for context-dependent effects of TGF-β. | Q37880676 | ||
Transforming growth factor beta1 inhibits collagenase 3 expression by transcriptional and post-transcriptional mechanisms in osteoblast cultures | Q38349014 | ||
Impact of Smad3 loss of function on scarring and adhesion formation during tendon healing. | Q38681589 | ||
Locally delivered rhTGF-beta2 enhances bone ingrowth and bone regeneration at local and remote sites of skeletal injury | Q39565797 | ||
TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation | Q39645151 | ||
MAN1, an integral protein of the inner nuclear membrane, binds Smad2 and Smad3 and antagonizes transforming growth factor-beta signaling. | Q40480429 | ||
Transforming growth factor-beta 1 regulation of collagenase-3 expression in osteoblastic cells by cross-talk between the Smad and MAPK signaling pathways and their components, Smad2 and Runx2. | Q40585969 | ||
Transforming growth factor-beta 1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein | Q40682198 | ||
Stimulation of osteoprotegerin (OPG) gene expression by transforming growth factor-beta (TGF-beta). Mapping of the OPG promoter region that mediates TGF-beta effects | Q40792736 | ||
Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass. | Q41689026 | ||
Transforming growth factor-beta induces osteoclast ruffling and chemotaxis: potential role in osteoclast recruitment. | Q43671898 | ||
Proteolysis of latent transforming growth factor-beta (TGF-beta )-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix. | Q43945272 | ||
Otolaryngological manifestations of cleidocranial dysplasia, concentrating on audiological findings | Q44018916 | ||
TGFbeta3 and loading increases osteocyte survival in human cancellous bone cultured ex vivo. | Q46183780 | ||
Inhibiting and stimulating effects of TGF-beta 1 on osteoclastic bone resorption in fetal mouse bone organ cultures | Q46192845 | ||
A natural history of cleidocranial dysplasia. | Q50489481 | ||
Mechanical loading stimulates rapid changes in periosteal gene expression. | Q52212548 | ||
The effect of hemopoietic growth factors on the generation of osteoclast-like cells in mouse bone marrow cultures. | Q54328238 | ||
Mutations in the gene encoding the latency-associated peptide of TGF-β1 cause Camurati-Engelmann disease | Q57849197 | ||
Role of Transforming Growth Factor-? in Fracture Repair | Q60146961 | ||
Activation of the bone-derived latent TGF beta complex by isolated osteoclasts | Q61961261 | ||
Chemotactic response of osteoblastlike cells to transforming growth factor beta | Q68601465 | ||
Glucocorticoid-induced activation of latent transforming growth factor-beta by normal human osteoblast-like cells | Q70492732 | ||
Osteoclast synthesis and secretion and activation of latent transforming growth factor beta | Q72058811 | ||
Local injection of TGF-beta increases the strength of tibial fractures in the rat | Q72354873 | ||
Transforming growth factor-beta enhances fracture healing in rabbit tibiae | Q72599377 | ||
Endogenous production of TGF-beta is essential for osteoclastogenesis induced by a combination of receptor activator of NF-kappa B ligand and macrophage-colony-stimulating factor | Q73086161 | ||
The bone remodeling compartment: a circulatory function for bone lining cells | Q74488805 | ||
p57(Kip2) is degraded through the proteasome in osteoblasts stimulated to proliferation by transforming growth factor beta1 | Q77353495 | ||
Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells | Q77630549 | ||
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 255 | |
P577 | publication date | 2013-01-09 | |
P1433 | published in | BoneKEy reports | Q27724456 |
P1476 | title | Regulation of postnatal bone homeostasis by TGFβ | |
P478 | volume | 2 |
Q50466779 | A comparison of the in vitro mineralisation and dentinogenic potential of mesenchymal stem cells derived from adipose tissue, bone marrow and dental pulp. |
Q64889366 | Ageing characteristics of bone indicated by transcriptomic and exosomal proteomic analysis of cortical bone cells. |
Q34051287 | Biological regulation of bone quality |
Q26739893 | Blood vessel formation and function in bone |
Q30861866 | CADASIL and CARASIL. |
Q55360793 | CCL4 enhances preosteoclast migration and its receptor CCR5 downregulation by RANKL promotes osteoclastogenesis. |
Q92185702 | Cathepsin K-deficient osteocytes prevent lactation-induced bone loss and parathyroid hormone suppression |
Q38761962 | Cytokines during periodontal wound healing: potential application for new therapeutic approach |
Q40096097 | Diabetes-induced fibrotic matrix inhibits intramembranous bone healing |
Q37718338 | Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in bone |
Q36769635 | Fam3c modulates osteogenic cell differentiation and affects bone volume and cortical bone mineral density |
Q41489760 | Fibrosis markers, hip fracture risk, and bone density in older adults |
Q88658775 | Genetic Engineering of Mesenchymal Stem Cells for Differential Matrix Deposition on 3D Woven Scaffolds |
Q92066450 | How much do we know about the role of osteocytes in different phases of fracture healing? A systematic review |
Q36060024 | Identification of Nedd9 as a TGF-β-Smad2/3 Target Gene Involved in RANKL-Induced Osteoclastogenesis by Comprehensive Analysis. |
Q51737164 | Impaired proteoglycan glycosylation, elevated TGF-β signaling, and abnormal osteoblast differentiation as the basis for bone fragility in a mouse model for gerodermia osteodysplastica. |
Q36923713 | Mechanobiology of TGFβ signaling in the skeleton |
Q38834639 | Mitotic Inheritance of mRNA Facilitates Translational Activation of the Osteogenic-Lineage Commitment Factor Runx2 in Progeny of Osteoblastic Cells. |
Q37477767 | Old age and the associated impairment of bones' adaptation to loading are associated with transcriptomic changes in cellular metabolism, cell-matrix interactions and the cell cycle. |
Q45978159 | Osteocyte-Intrinsic TGF-β Signaling Regulates Bone Quality through Perilacunar/Canalicular Remodeling. |
Q89389543 | Phenotype and Viability of MLO-Y4 Cells Is Maintained by TGFβ₃ in a Serum-Dependent Manner within a 3D-Co-Culture with MG-63 Cells |
Q33965312 | Post-transcriptional regulation in osteoblasts using localized delivery of miR-29a inhibitor from nanofibers to enhance extracellular matrix deposition |
Q38699865 | Proteomics approach to identify novel metastatic bone markers from the secretome of PC-3 prostate cancer cells |
Q39155183 | TGF-β Family Signaling in Connective Tissue and Skeletal Diseases |
Q57289200 | TGF-β2 downregulates osteogenesis under inflammatory conditions in dental follicle stem cells |
Q41474810 | TGFβ1 - induced recruitment of human bone mesenchymal stem cells is mediated by the primary cilium in a SMAD3-dependent manner. |
Q35750113 | TNF Induction of NF-κB RelB Enhances RANKL-Induced Osteoclastogenesis by Promoting Inflammatory Macrophage Differentiation but also Limits It through Suppression of NFATc1 Expression |
Q41787449 | Unlocking the bone: Fcγ-receptors and antibody glycosylation are keys to connecting bone homeostasis to humoral immunity |